Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Early-Stage Biopharma Investors Opt for Safer Bets in 2002

Jan 01 2003

• By Heather Slowik

Related Content

Sention Inc.

Nov 01 2002

RNAi Revs Up

Oct 01 2002

Private Equity Fund IRRs Disclosed But Questions Linger

Dec 01 2002

Related Companies

Kalypsys, Inc.

AstraZeneca PLC

Ardea Biosciences, Inc.

Barrier Therapeutics

Johnson & Johnson

PDL BioPharma, Inc.

Wyeth

Alexza Pharmaceuticals, Inc.

Maxygen, Inc.

Codexis, Inc.

Sireen AG

Archemix Corp.

Gilead Sciences, Inc.

Alnylam Pharmaceuticals Inc.

Additional Topics

Strategy Business Strategies Platform Technologies BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window